Pioneering sophisticated technologies for
sleep disorders &
movement disorders
to improve the quality of life for people around the world.
1.877.CLEVEMED (1.877.253.8363)
1.877.CLEVEMED (1.877.253.8363)
CleveMed Movement Disorders Literature
News Releases
- CleveMed receives ISO 13485:2003, CMDCAS and MDD 93/42/EEC certifications
- Joseph Giuffrida, PhD appointed to CleveMed Vice President, General Manager
- CleveMed Assists AMA in Release of CPT Code for Recording Physiologic Tremor
- CleveMed Issues Online UPDRS Scoring Challenge to Highlight Benefits of Kinesia™ Automated Tremor Scoring
- CleveMed launches clinical study monitoring Parkinson's Disease motor symptoms in the clinic and at home using Kinesia™
- CleveMed receives $1.23 million in NIH funding to develop a system to augment Deep Brain Stimulation Programming in Parkinson's Disease
- Frost & Sullivan Lauds CleveMed for Kinesia, a Revolutionary Mobility Disorder Monitoring System
- CleveMed´s Kinesia device awarded Neurotech Business Report´s "Gold Electrode Award" for Best New Product
- CleveMed Receives FDA Clearance To Market Wireless Movement Disorder Monitor
- CleveMed awarded $896,000 NIH Grant to help stroke patients recover lost motor function
Publications
- "Correlation between Kinesia System Assessments and Clinical TETRAS Scores in Patients with Essential Tremor" Movement Disorder Society Congress, Paris, France, June 2009
- "Clinically Deployable Kinesia Technology for Automated Tremor Assessment," by Joseph P. Giuffrida, PhD, David E. Riley MD, Brian N. Maddux, MD, Dustin A. Heldman, PhD, as seen in the Movement Disorders Journal
- "Upper-Extremity Stroke Therapy Task Discrimination Using Motion Sensors and Electromyography," as seen in IEEE Transactions on Neural Systems and Rehabilitation Engineering, Vol. 16, No. 1, February 2008
- ParkinSense™: A Wireless Movement Disorder Quantification System
